OpenAI has announced the acquisition of startup Orchestra Bio. The move is intended to bolster the company’s efforts in the life sciences sector by integrating Orchestra’s specialized team and technology into its ongoing projects.
Specifically, the acquisition supports the development of Rosalind, an AI model designed for life sciences research. In addition to the model itself, the integration will extend to the Rosalind Workbench, a tool developed by OpenAI to assist researchers in planning scientific experiments and analyzing complex datasets.
By incorporating Orchestra Bio’s expertise, OpenAI aims to enhance the utility of these tools for the research community, focusing on streamlining experimental workflows and data interpretation in life sciences.
Source: TechCrunch
Original article: https://techcrunch.com/2026/10/20/openai-acquires-startup-orchestra-bio%e2%81%a0-to-beef-up-its-biotech-business/
Leave a Reply